The Role of ITGAM in Systemic Lupus Erythematosus

N/ACompletedNCT01230112

Northwell Health40 enrolled

Overview

Study to examine the role of ITGAM molecule in normal control subjects with known genetic variation in the ITGAM gene.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Systemic Lupus Erythematosus

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * males and females, age 18 or older, enrolled in Genotype and Phenotype Registry, in general good health * Participants who carry the genotype of interest, based on a buccal or blood derived DNA sample Exclusion Criteria: * History of Systemic Lupus Erythematosus, rheumatoid arthritis, or other autoimmune disease * History of cancer or lymphoma * Current use of aspirin, prednisone, or NSAID or any immunosuppressant * Self reported HIV

Locations (1)

Feinstein Institute for Medical Research

Manhasset, New York, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.